Not exact matches
Potti and his colleagues began by testing chemotherapy drugs on cultured cell lines
from human
tumors, such as
from the
lung, breast, or ovary.
Then there was the researcher, just back
from Myanmar, panicked about a
tumor in his
lung.
They found out that TiY is capable of distinguishing TICs
from non-TICs in various human
lung cancer cell lines and patient - derived
lung tumors.
The substance vigorously inhibited the growth of cultured
tumor cells
from colon,
lung, and breast cancers, the team reports in the 20 January issue of Angewandte Chemie.
The researchers confirmed their observations by studying tissue
from lung cancer
tumors.
«FDG PET shows
tumor DNA levels in blood are linked to NSCLC aggressiveness: Insights derived
from FDG PET could improve treatment selection for patients with advanced non-small cell
lung cancer.»
Loss of either GSTO1 or RYR1, the researchers report, decreased the number of cancer stem cells in the primary
tumor, blocked metastasis of cancer cells
from the primary
tumor to the
lungs, decreased the duration of chemotherapy required to induce remission and increased the duration of time after chemotherapy was stopped that the mice remained
tumor - free.
Nana - Sinkam and his colleagues examined
lung -
tumor samples
from 81 patients with stage - 1 nonsmall - cell
lung cancer and
tumor - cell lines.
But
tumors from patients with distant metastases to the
lung and liver showed massive epigenetic changes that mapped to large, blocklike segments of the genome, both in the distant metastases themselves and in the section, or «subclone,» of the primary
tumors they came
from.
«High concordance between EGFR mutations
from circulating - free
tumor DNA and
tumor tissue in non-small cell
lung cancer.»
Epidermal growth factor receptor (EGFR) mutations found in the circulating free
tumor DNA (ctDNA)
from the plasma of advanced non-small cell
lung cancer (NSCLC) patients correlates well with the EGFR mutations
from patient - matched
tumor tissue DNA.
P: We found discodermolide [a drug
from Discodermia, a sponge found in the Caribbean, the Bahamas, and the Gulf of Mexico], and it's gone through phase I clinical trials for treatment of solid
tumors such as ovarian, pancreatic, breast, colon, or
lung cancers.
Various genetic testing methods were used to examine
lung tumors, uninvolved
lung tissue and normal - appearing airways located varying distances
from the
tumors.
«Almost half the deaths
from cancers result
from lung and breast cancer, both of which are solid
tumors.
In the Dec. 1 issue of Science, the team
from the MGH Center for Systems Biology describes a «crosstalk» between
lung tumors and bone marrow, which leads to the generation of a type of immune cell that travels to the
tumor and promotes its progression.
When the researchers removed FAK
from blood vessels that grew in melanoma or
lung cancer models, both chemotherapy and radiation therapies were far more effective in killing the
tumors.
Results of an initial study of
tumors from patients with
lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells.
«For example, mouse mammary
tumors shared a signaling pathway that is found in human
lung cancer and controls how cells reproduce and move
from one location to another.»
The current clinical trial uses information of air movement
from existing 4D CT data and «some equations,» says Vinogradskiy (diplomatically) to calculate
lung function in tissue surrounding
tumors.
The results
from our new study suggest that entinostat may enhance the anti-tumor efficacy of PD - 1 targeted therapy through MDSC targeting, potentially providing an effective combination treatment approach for patients with solid
tumors, including
lung and renal cell carcinoma.»
In one, a liver and armpit
tumor that had developed
from spreading melanoma cells shrank, and in the other a
lung tumor disappeared.
«Metastatic brain
tumors — often
from lung, breast or skin cancers — are the most commonly observed
tumors within the brain and account for about 40 percent of advanced melanoma metastases.
Another replication attempt supported a 2011 Science Translational Medicine report
from Stanford computational biologist Atul Butte's lab that the ulcer drug Tagamet slows the growth of
lung tumors in mice.
«Metastatic brain
tumors — often
from lung, breast or skin cancers — are the most commonly observed
tumors within the brain and account for about 30 percent of advanced breast cancer metastases,» says Khalid Shah, MS, PhD, director of the Molecular Neurotherapy and Imaging Laboratory in the MGH Departments of Radiology and Neurology, who led the study.
In these circumstances, cells
from primary
tumors in breast, colon, prostate, or other organs invade
lung tissue via the bloodstream.
An anti-PD-1 antibody developed by Bristol - Myers Squibb generates excitement with results
from a phase I trial showing that, among 236 patients with various types of cancer, the treatment shrank
tumors in 28 percent of melanoma patients, 30 percent of patients with kidney cancer, and 18 percent of patients with advanced non-small cell
lung cancer.
IHC - P mouse
tumor tissue (
from lung) with human cell line injected, some muscle tissue attached as well sees high background for human cellswith priamry Ab as well as isotype ctrl, but also for muscle (does not contain any EGF) Ab: 1 ug /...
Surgery for carcinoid
tumor of the
lung hasn't prevented John Williams
from taking 15 - mile bike rides «without a problem.»
The team examined premalignant as well as cancer cells
from breast and
lung tumors and matched normal and premalignant breast cells
from healthy women provided by scientists at the University of California San Francisco.
Five to six weeks after the resection of primary
tumors from tumor - bearing NOD / SCID mice,
lungs were harvested and fixed in the Bouin's fixative solution overnight.
The sum of metastatic
tumor volume was first calculated
from four lobes of
lungs per animal (see Materials and methods), and the
lung metastasis per group is presented as
tumor volume (cubic millimeters).
With the recent presentation of the data
from Keynote - 024, and the recent approval of pembrolizumab for high PD - L1 expressing
tumors, the landscape of
lung cancer oncology will change dramatically and for the better.
In this fashion, they derive a signal
from the
tumor cells proportional to
tumor mass which arises spontaneously in vivo in the accurate setting of the
lung and
from the accurate genetic lesions found in human non-small cell
lung cancer (NSCLC).
Lung metastases
from the
tumor - initiating assays.
A CT scan showed
tumors ranging in size
from 0.4 to 4.4 centimeters in his neck, lymph nodes,
lungs and liver.
Tens of thousands of Americans with
tumors from certain types of
lung cancer have mutations that might be treated by...
Most
tumors contain fewer than 10 of the driver mutations, but the number of total mutations — passenger and driver — can climb far higher,
from a dozen or so in neuroblastoma to approximately 200 in
lung cancer.
Metastatic
tumor burden of each animal was calculated by combining
tumor volumes
from four lobes of
lungs.
These interests grew
from studies of paraneoplastic neurologic disorders (PNDs), a group of diseases thought to arise when
tumors — typically breast, ovarian, or
lung cancers — start making proteins normally only made by the brain.
A new biomarker is 98 percent effective at distinguishing benign
from malignant
lung tumors.
DNA Detectives Find Genetic Markers for
Lung Cancers Most Likely to Recur Researchers at the Johns Hopkins Kimmel Cancer Center uncovered clearly recognizable genetic alterations in tumors and tissue removed from patients with early - stage lung cancers that look like good predictors of which of these cancers are more likely to re
Lung Cancers Most Likely to Recur Researchers at the Johns Hopkins Kimmel Cancer Center uncovered clearly recognizable genetic alterations in
tumors and tissue removed
from patients with early - stage
lung cancers that look like good predictors of which of these cancers are more likely to re
lung cancers that look like good predictors of which of these cancers are more likely to recur.
The Program specializes in the treatment of primary head and neck cancers, brain and spine
tumors such as squamous cell carcinoma, basal cell cancer, glomus
tumor, paragangliomas, acoustic neuromas, salivary gland and mucosal
tumors, astrocytomas, oligodendrogliomas, glioblastomas, and hemangioblastomas, and metastatic
tumors that may have arisen
from elsewhere in the body such as the breast,
lung, or prostate.
The company's initial goal is to identify and deploy therapeutic neo-antigens
from individual patients»
tumors to develop novel treatments for
lung cancer.
One example: In stage 4 breast cancer, the
tumor may have spread
from the breast to the bones, brain, liver, or
lungs.
A 2012 Japanese study found the pulp and juice
from satsuma mandarin oranges inhibited
tumor growth in cancers of the colon,
lung and tongue.
What I learned
from the supervising vet was that 50 % of those malignant mammary
tumors have already metastasized to the
lungs by the time of diagnosis.
The blood can be coming
from your dog's
lungs, pharynx, esophagus, stomach, or upper (small) intestine and this can mean a serious disorder such as a
tumor.
These diseases include infectious pneumonia (fungal, bacterial, parasitic), feline heartworm disease (cats are aberrant hosts for the canine heartworm disease parasite), primary
lung parasites, and
tumor disease (either a
lung tumor, or one that has metastasized or spread to the
lungs from elsewhere in the body).
Another main trigger is the involuntary movement of the hairlike cilia in the respiratory tract which remove foreign matter
from the air before it gets into the
lungs, but other underlying causes can include mucous irritation, obstruction of the nasal passage, inflammation, excess nasal discharge or secretion, pneumonia, chronic vomiting, GI disease, and nasal
tumors and dental diseases in older dogs.
These secondary or metastatic
tumors are sometimes difficult to distinguish
from multiple
tumors originating in the
lung.